TY - JOUR AU - Platt, F. M. AU - d'Azzo, A. AU - Davidson, B. L. AU - Neufeld, E. F. AU - Tifft, C. J. PY - 2018 DA - 2018// TI - Lysosomal storage diseases JO - Nat Rev Dis Primers VL - 4 UR - https://doi.org/10.1038/s41572-018-0025-4 DO - 10.1038/s41572-018-0025-4 ID - Platt2018 ER - TY - JOUR AU - Fratantoni, J. C. AU - Hall, C. W. AU - Neufeld, E. F. PY - 1969 DA - 1969// TI - The defect in Hurler and Hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation JO - Proc Natl Acad Sci USA VL - 64 UR - https://doi.org/10.1073/pnas.64.1.360 DO - 10.1073/pnas.64.1.360 ID - Fratantoni1969 ER - TY - JOUR AU - Ries, M. PY - 2017 DA - 2017// TI - Enzyme replacement therapy and beyond—in memoriam. Roscoe O. Brady, M.D. (1923–2016) JO - J Inherit Metab Dis VL - 40 UR - https://doi.org/10.1007/s10545-017-0032-8 DO - 10.1007/s10545-017-0032-8 ID - Ries2017 ER - TY - JOUR AU - Beutler, E. AU - Kay, A. AU - Saven, A. AU - Garver, P. AU - Thurston, D. AU - Dawson, A. PY - 1991 DA - 1991// TI - Enzyme replacement therapy for Gaucher disease JO - Blood VL - 78 UR - https://doi.org/10.1182/blood.V78.5.1183.1183 DO - 10.1182/blood.V78.5.1183.1183 ID - Beutler1991 ER - TY - JOUR AU - Leal, A. F. AU - Espejo-Mojica, A. J. AU - Sánchez, O. F. AU - Ramírez, C. M. AU - Reyes, L. H. AU - Cruz, J. C. PY - 2020 DA - 2020// TI - Lysosomal storage diseases: current therapies and future alternatives JO - J Mol Med (Berl) VL - 98 UR - https://doi.org/10.1007/s00109-020-01935-6 DO - 10.1007/s00109-020-01935-6 ID - Leal2020 ER - TY - JOUR AU - Pearse, Y. AU - Iacovino, M. PY - 2020 DA - 2020// TI - A cure for Sanfilippo syndrome? A summary of current therapeutic approaches and their promise JO - Med Res Arch UR - https://doi.org/10.18103/mra.v8i2.2045 DO - 10.18103/mra.v8i2.2045 ID - Pearse2020 ER - TY - JOUR AU - Suzuki, Y. PY - 2020 DA - 2020// TI - Chaperone therapy for molecular pathology in lysosomal diseases JO - Brain Dev VL - S0387–7604 ID - Suzuki2020 ER - TY - JOUR AU - Feriozzi, S. AU - Hughes, D. A. PY - 2020 DA - 2020// TI - New drugs for the treatment of Anderson–Fabry disease JO - J Nephrol UR - https://doi.org/10.1007/s40620-020-00721-4 DO - 10.1007/s40620-020-00721-4 ID - Feriozzi2020 ER - TY - JOUR AU - Concolino, D. AU - Deodato, F. AU - Parini, R. PY - 2018 DA - 2018// TI - Enzyme replacement therapy: efficacy and limitations JO - Ital J Pediatr VL - 44 UR - https://doi.org/10.1186/s13052-018-0562-1 DO - 10.1186/s13052-018-0562-1 ID - Concolino2018 ER - TY - JOUR AU - Sato, Y. AU - Okuyama, T. PY - 2020 DA - 2020// TI - Novel enzyme replacement therapies for neuropathic mucopolysaccharidoses JO - Int J Mol Sci VL - 21 UR - https://doi.org/10.3390/ijms21020400 DO - 10.3390/ijms21020400 ID - Sato2020 ER - TY - JOUR AU - Iqubal, A. AU - Iqubal, M. K. AU - Khan, A. AU - Ali, J. AU - Baboota, S. AU - Haque, S. E. PY - 2020 DA - 2020// TI - Gene therapy, a novel therapeutic tool for neurological disorders: current progress, challenges and future prospective JO - Curr Gene Ther UR - https://doi.org/10.2174/1566523220999200716111502 DO - 10.2174/1566523220999200716111502 ID - Iqubal2020 ER - TY - JOUR AU - Blumenreich, S. AU - Yaacobi, C. AU - Vardi, A. AU - Barav, O. B. AU - Vitner, E. B. AU - Park, H. PY - 2020 DA - 2020// TI - Substrate reduction therapy using Genz-667161 reduces levels of pathogenic components in a mouse model of neuronopathic forms of Gaucher disease JO - J Neurochem UR - https://doi.org/10.1111/jnc.15136 DO - 10.1111/jnc.15136 ID - Blumenreich2020 ER - TY - JOUR AU - Clarke, J. T. AU - Amato, D. AU - Deber, R. B. PY - 2001 DA - 2001// TI - Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario JO - CMAJ VL - 165 ID - Clarke2001 ER - TY - JOUR AU - Parker, H. AU - Bigger, B. W. PY - 2019 DA - 2019// TI - The role of innate immunity in mucopolysaccharide diseases JO - J Neurochem VL - 148 ID - Parker2019 ER - TY - JOUR AU - Ren, H. AU - Wang, G. PY - 2020 DA - 2020// TI - Autophagy and lysosomal storage disorders JO - Adv Exp Med Biol VL - 1207 UR - https://doi.org/10.1007/978-981-15-4272-5_5 DO - 10.1007/978-981-15-4272-5_5 ID - Ren2020 ER - TY - JOUR AU - Stepien, K. M. AU - Roncaroli, F. AU - Turton, N. AU - Hendriksz, C. J. AU - Roberts, M. AU - Heaton, R. A. PY - 2020 DA - 2020// TI - Mechanisms of mitochondrial dysfunction in lysosomal storage disorders: a review JO - J Clin Med VL - 9 UR - https://doi.org/10.3390/jcm9082596 DO - 10.3390/jcm9082596 ID - Stepien2020 ER - TY - JOUR AU - Chanda, D. AU - Neumann, D. AU - Glatz, J. F. C. PY - 2019 DA - 2019// TI - The endocannabinoid system: overview of an emerging multi-faceted therapeutic target JO - Prostaglandins Leukot Essent Fatty Acids VL - 140 UR - https://doi.org/10.1016/j.plefa.2018.11.016 DO - 10.1016/j.plefa.2018.11.016 ID - Chanda2019 ER - TY - JOUR AU - Murphy, T. AU - Foll, B. PY - 2020 DA - 2020// TI - Targeting the endocannabinoid CB1 receptor to treat body weight disorders: a preclinical and clinical review of the therapeutic potential of past and present CB1 drugs JO - Biomolecules VL - 10 UR - https://doi.org/10.3390/biom10060855 DO - 10.3390/biom10060855 ID - Murphy2020 ER - TY - JOUR AU - Russo, S. AU - Azevedo, W. F. PY - 2019 DA - 2019// TI - Advances in the understanding of the cannabinoid receptor 1 - focusing on the inverse agonists interactions JO - Curr Med Chem VL - 26 UR - https://doi.org/10.2174/0929867325666180417165247 DO - 10.2174/0929867325666180417165247 ID - Russo2019 ER - TY - JOUR AU - Bie, B. AU - Wu, J. AU - Foss, J. F. AU - Naguib, M. PY - 2018 DA - 2018// TI - An overview of the cannabinoid type 2 receptor system and its therapeutic potential JO - Curr Opin Anaesthesiol VL - 31 UR - https://doi.org/10.1097/ACO.0000000000000616 DO - 10.1097/ACO.0000000000000616 ID - Bie2018 ER - TY - JOUR AU - Hussain, M. T. AU - Greaves, D. R. AU - Iqbal, A. J. PY - 2019 DA - 2019// TI - The impact of cannabinoid receptor 2 deficiency on neutrophil recruitment and inflammation JO - DNA Cell Biol VL - 38 UR - https://doi.org/10.1089/dna.2019.5024 DO - 10.1089/dna.2019.5024 ID - Hussain2019 ER - TY - JOUR AU - Cooray, R. AU - Gupta, V. AU - Suphioglu, C. PY - 2020 DA - 2020// TI - Current aspects of the endocannabinoid system and targeted THC and CBD phytocannabinoids as potential therapeutics for Parkinson's and Alzheimer's Diseases: a review JO - Mol Neurobiol UR - https://doi.org/10.1007/s12035-020-02054-6 DO - 10.1007/s12035-020-02054-6 ID - Cooray2020 ER - TY - JOUR AU - Fazio, D. AU - Criscuolo, E. AU - Piccoli, A. AU - Barboni, B. AU - Fezza, F. AU - Maccarrone, M. PY - 2020 DA - 2020// TI - Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? JO - Expert Opin Drug Discov VL - 15 UR - https://doi.org/10.1080/17460441.2020.1751118 DO - 10.1080/17460441.2020.1751118 ID - Fazio2020 ER - TY - JOUR AU - Mallipeddi, S. AU - Janero, D. R. AU - Zvonok, N. AU - Makriyannis, A. PY - 2017 DA - 2017// TI - Functional selectivity at G-protein coupled receptors: advancing cannabinoid receptors as drug targets JO - Biochem Pharmacol VL - 128 UR - https://doi.org/10.1016/j.bcp.2016.11.014 DO - 10.1016/j.bcp.2016.11.014 ID - Mallipeddi2017 ER - TY - JOUR AU - Reggio, P. H. PY - 2010 DA - 2010// TI - Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown JO - Curr Med Chem VL - 17 UR - https://doi.org/10.2174/092986710790980005 DO - 10.2174/092986710790980005 ID - Reggio2010 ER - TY - JOUR AU - Scala, C. AU - Fantini, J. AU - Yahi, N. AU - Barrantes, F. J. AU - Chahinian, H. PY - 2018 DA - 2018// TI - Anandamide revisited: how cholesterol and ceramides control receptor-dependent and receptor-independent signal transmission pathways of a lipid neurotransmitter JO - Biomolecules VL - 8 UR - https://doi.org/10.3390/biom8020031 DO - 10.3390/biom8020031 ID - Scala2018 ER - TY - JOUR AU - Paugh, S. W. AU - Cassidy, M. P. AU - He, H. AU - Milstien, S. AU - Sim-Selley, L. J. AU - Spiegel, S. PY - 2006 DA - 2006// TI - Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor JO - Mol Pharmacol VL - 70 UR - https://doi.org/10.1124/mol.105.020552 DO - 10.1124/mol.105.020552 ID - Paugh2006 ER - TY - JOUR AU - Rimmerman, N. AU - Bradshaw, H. B. AU - Kozela, E. AU - Levy, R. AU - Juknat, A. AU - Vogel, Z. PY - 2012 DA - 2012// TI - Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1 JO - Br J Pharmacol VL - 165 UR - https://doi.org/10.1111/j.1476-5381.2011.01380.x DO - 10.1111/j.1476-5381.2011.01380.x ID - Rimmerman2012 ER - TY - JOUR AU - Oddi, S. AU - Caporali, P. AU - Dragotto, J. AU - Totaro, A. AU - Maiolati, M. AU - Scipioni, L. PY - 2019 DA - 2019// TI - The endocannabinoid system is affected by cholesterol dyshomeostasis: Insights from a murine model of Niemann Pick type C disease JO - Neurobiol Dis VL - 130 UR - https://doi.org/10.1016/j.nbd.2019.104531 DO - 10.1016/j.nbd.2019.104531 ID - Oddi2019 ER - TY - JOUR AU - Sánchez, C. AU - Galve-Roperh, I. AU - Rueda, D. AU - Guzmán, M. PY - 1998 DA - 1998// TI - Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes JO - Mol Pharmacol VL - 54 UR - https://doi.org/10.1124/mol.54.5.834 DO - 10.1124/mol.54.5.834 ID - Sánchez1998 ER - TY - JOUR AU - Schuchman, E. H. AU - Desnick, R. J. PY - 2017 DA - 2017// TI - Types A and B Niemann-Pick disease JO - Mol Genet Metab VL - 120 UR - https://doi.org/10.1016/j.ymgme.2016.12.008 DO - 10.1016/j.ymgme.2016.12.008 ID - Schuchman2017 ER - TY - JOUR AU - Scandroglio, F. AU - Venkata, J. K. AU - Loberto, N. AU - Prioni, S. AU - Schuchman, E. H. AU - Chigorno, V. PY - 2008 DA - 2008// TI - Lipid content of brain, brain membrane lipid domains, and neurons from acid sphingomyelinase deficient mice JO - J Neurochem VL - 107 UR - https://doi.org/10.1111/j.1471-4159.2008.05591.x DO - 10.1111/j.1471-4159.2008.05591.x ID - Scandroglio2008 ER - TY - JOUR AU - Thurberg, B. L. AU - Diaz, G. A. AU - Lachmann, R. H. AU - Schiano, T. AU - Wasserstein, M. P. AU - Ji, A. J. PY - 2020 DA - 2020// TI - Long-term efficacy of olipudase alfa in adults with acid sphingomyelinase deficiency (ASMD): Further clearance of hepatic sphingomyelin is associated with additional improvements in pro- and anti-atherogenic lipid profiles after 42 months of treatment JO - Mol Genet Metab UR - https://doi.org/10.1016/j.ymgme.2020.06.010 DO - 10.1016/j.ymgme.2020.06.010 ID - Thurberg2020 ER - TY - JOUR AU - Horinouchi, K. AU - Erlich, S. AU - Perl, D. P. AU - Ferlinz, K. AU - Bisgaier, C. L. AU - Sandhoff, K. PY - 1995 DA - 1995// TI - Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease JO - Nat Genet VL - 10 UR - https://doi.org/10.1038/ng0795-288 DO - 10.1038/ng0795-288 ID - Horinouchi1995 ER - TY - STD TI - Bartoll A, Toledano-Zaragoza A, Casas J, Guzman M, Schuchman EH, Ledesma MD. Inhibition of fatty acid amide hydrolase prevents pathology in neurovisceral acid sphingomyelinase deficiency by rescuing defective endocannabinoid signaling. EMBO Mol Med. 2020; e11776. ID - ref35 ER - TY - JOUR AU - Devlin, C. AU - Pipalia, N. H. AU - Liao, X. AU - Schuchman, E. H. AU - Maxfield, F. R. AU - Tabas, I. PY - 2010 DA - 2010// TI - Improvement in lipid and protein trafficking in Niemann-Pick C1 cells by correction of a secondary enzyme defect JO - Traffic VL - 11 UR - https://doi.org/10.1111/j.1600-0854.2010.01046.x DO - 10.1111/j.1600-0854.2010.01046.x ID - Devlin2010 ER - TY - JOUR AU - Alayoubi, A. M. AU - Wang, J. C. AU - Au, B. C. AU - Carpentier, S. AU - Garcia, V. AU - Dworski, S. PY - 2013 DA - 2013// TI - Systemic ceramide accumulation leads to severe and varied pathological consequences JO - EMBO Mol Med VL - 5 UR - https://doi.org/10.1002/emmm.201202301 DO - 10.1002/emmm.201202301 ID - Alayoubi2013 ER - TY - JOUR AU - Bhaumik, M. AU - Muller, V. J. AU - Rozaklis, T. AU - Johnson, L. AU - Dobrenis, K. AU - Bhattacharyya, R. PY - 1999 DA - 1999// TI - A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome) JO - Glycobiology VL - 9 UR - https://doi.org/10.1093/glycob/9.12.1389 DO - 10.1093/glycob/9.12.1389 ID - Bhaumik1999 ER - TY - JOUR AU - Salazar, M. AU - Carracedo, A. AU - Salanueva, I. J. AU - Hernández-Tiedra, S. AU - Lorente, M. AU - Egia, A. PY - 2009 DA - 2009// TI - Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells JO - J Clin Invest VL - 119 UR - https://doi.org/10.1172/JCI37948 DO - 10.1172/JCI37948 ID - Salazar2009 ER - TY - JOUR AU - Fernández-Ruiz, J. AU - Romero, J. AU - Ramos, J. A. PY - 2015 DA - 2015// TI - Endocannabinoids and neurodegenerative disorders: Parkinson's disease, Huntington's Chorea, Alzheimer's disease, and others JO - Handb Exp Pharmacol VL - 231 UR - https://doi.org/10.1007/978-3-319-20825-1_8 DO - 10.1007/978-3-319-20825-1_8 ID - Fernández-Ruiz2015 ER - TY - JOUR AU - Wójcik, P. AU - Žarković, N. AU - Gęgotek, A. AU - Skrzydlewska, E. PY - 2020 DA - 2020// TI - Involvement of metabolic lipid mediators in the regulation of apoptosis JO - Biomolecules VL - 10 UR - https://doi.org/10.3390/biom10030402 DO - 10.3390/biom10030402 ID - Wójcik2020 ER - TY - JOUR AU - Rovira-Esteban, L. AU - Péterfi, Z. AU - Vikór, A. AU - Máté, Z. AU - Szabó, G. AU - Hájos, N. PY - 2017 DA - 2017// TI - Morphological and physiological properties of CCK/CB1R-expressing interneurons in the basal amygdala JO - Brain Struct Funct VL - 222 UR - https://doi.org/10.1007/s00429-017-1417-z DO - 10.1007/s00429-017-1417-z ID - Rovira-Esteban2017 ER - TY - JOUR AU - Vendel, E. AU - Lange, E. C. PY - 2014 DA - 2014// TI - Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier JO - Neuromol Med VL - 16 UR - https://doi.org/10.1007/s12017-014-8314-x DO - 10.1007/s12017-014-8314-x ID - Vendel2014 ER - TY - JOUR AU - Siegmund, S. V. AU - Schwabe, R. F. PY - 2008 DA - 2008// TI - Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis JO - Am J Physiol Gastrointest Liver Physiol VL - 294 UR - https://doi.org/10.1152/ajpgi.00456.2007 DO - 10.1152/ajpgi.00456.2007 ID - Siegmund2008 ER - TY - JOUR AU - García, S. AU - Martín Giménez, V. M. AU - Mocayar Marón, F. J. AU - Reiter, R. J. AU - Manucha, W. PY - 2020 DA - 2020// TI - Melatonin and cannabinoids: mitochondrial-targeted molecules that may reduce inflammaging in neurodegenerative diseases JO - Histol Histopathol VL - 35 ID - García2020 ER - TY - JOUR AU - Mecha, M. AU - Yanguas-Casás, N. AU - Feliú, A. AU - Mestre, L. AU - Carrillo-Salinas, F. AU - Azcoitia, I. PY - 2019 DA - 2019// TI - The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia JO - Brain Behav Immun VL - 77 UR - https://doi.org/10.1016/j.bbi.2018.12.013 DO - 10.1016/j.bbi.2018.12.013 ID - Mecha2019 ER - TY - JOUR AU - Piette, C. AU - Cui, Y. AU - Gervasi, N. AU - Venance, L. PY - 2020 DA - 2020// TI - Lights on endocannabinoid-mediated synaptic potentiation JO - Front Mol Neurosci VL - 13 UR - https://doi.org/10.3389/fnmol.2020.00132 DO - 10.3389/fnmol.2020.00132 ID - Piette2020 ER -